Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 115 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy				Phase IV				AVO108943 NCT00470834
	Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer				Phase III, Phase II				G050103 NCT00295802
	Phase III Randomized Trial of Suicide Gene Therapy and Prostate Cancer				Phase III, Phase II				Prostate4809 P01 CA098012, NCT00583492
	Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer				Phase III, Phase II				UIC-2006-0706 2006-0706, NCT00765479
	Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer				Phase III				RTOG-0232 CTSU, NCT00063882
	Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer				Phase III				FCCC-03028 NCT00084552
	Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer				Phase III				05-043 NCT00116142
	Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer				Phase III				05-007 NCT00142506
	Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma				Phase III				553 NCT00132301
	Low Dose Supplemental External Radiation With pd-103 vs pd-103 Alone for Prostate Cancer				Phase III				04-8-10 NCT00241384


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute